scholarly journals Response to the Coronavirus Disease-2019 Pandemic: Lessons Learned from the Taiwan Model

2020 ◽  
Vol 16 (10) ◽  
pp. 16
Author(s):  
Charles Wu ◽  
Catherine Wu ◽  
Kun Chan Wu

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or coronavirus disease-2019 (COVID-19), emerged in December 2019 in Wuhan, China and has since then spurred a global pandemic (Lai et al., 2020). Taiwan and China, separated only by 130 km across the Taiwan Strait, have frequent cross-strait interactions with each other; millions of people travel to and from between the two countries (Wang & Lin, 2020). Considering these facts, Lauren Gardner, an associate professor at the Johns Hopkins University, even predicted that Taiwan will have the second highest number of COVID-19 cases among the world using a metapopulation model (Gardner et al., 2020). However, with a population of 23.7 million people, Taiwan leads one of the least COVID-19 cases worldwide. With the help of technology, swift reactions, advanced deployment of resources, and complete transparency, the Taiwan model has made its success. By analyzing the actions taken and how they functioned in Taiwan in preventing a nationwide epidemic, other countries may benefit in understanding how to design better models for the prevention of future epidemics and pandemics.

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 748-752
Author(s):  
Swapnali Khabade ◽  
Bharat Rathi ◽  
Renu Rathi

A novel, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes severe acute respiratory syndrome and spread globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus as a COVID- 19, a global pandemic. This pandemic happened to be followed by some restrictions, and specially lockdown playing the leading role for the people to get disassociated with their personal and social schedules. And now the food is the most necessary thing to take care of. It seems the new challenge for the individual is self-isolation to maintain themselves on the health basis and fight against the pandemic situation by boosting their immunity. Food organised by proper diet may maintain the physical and mental health of the individual. Ayurveda aims to promote and preserve the health, strength and the longevity of the healthy person and to cure the disease by properly channelling with and without Ahara. In Ayurveda, diet (Ahara) is considered as one of the critical pillars of life, and Langhana plays an important role too. This article will review the relevance of dietetic approach described in Ayurveda with and without food (Asthavidhi visheshaytana & Lanhgan) during COVID-19 like a pandemic.


2021 ◽  
Vol 9 (2) ◽  
pp. 60-69
Author(s):  
Ridwan Olamilekan Adesola ◽  
Oluwatobi Emmanuel Oladele ◽  
Ahmed Oluwasegun Tajudeen ◽  
Ogundepo Oluwatobi Moses ◽  
Murali Dinesh

Coronavirus disease 2019 (COVID-19), confirmed as the global pandemic on March 11, 2020, by the World Health Organization (WHO), was caused by the outbreak of an emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in Wuhan city, China, in December 2019. Based on the previous pandemic, such as severe acute respiratory syndrome (SARS) from 2002 to 2003, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. The scientific developments have fast-tracked our insights SARS-CoV-2 epidemiology, likewise vaccinology relevant for developing drugs for viral infections treatment. As there are not many detailed interventions and vaccines available for disease control, the pandemic COVID-19 poses countless threats to global public health, causing a great level of insecurity and unrest worldwide. To provide an inclusive overview to global health authorities and prospective readers worldwide, we detailed in this review the epidemiology and vaccinology of SARS-CoV-2 in Nigeria.


2020 ◽  
Vol 54 (4s) ◽  
pp. 1-2
Author(s):  
David Ofori-Adjei ◽  
Margaret Lartey ◽  
Kwadwo A. Koram

A new virus causing predominantly respiratory tract infection was described in China late 2019. The virus was subsequently named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes as COVID-19. Subsequently the virus spread to many parts of the world. This resulted in the World Health Organisation declaring COVID-19 a global pandemic on 11th March 2020.


2021 ◽  
pp. 38-42
Author(s):  
Charles Haddad ◽  
Christopher Scuderi ◽  
Judelle Haddad-Lacle ◽  
Reetu Grewal ◽  
Jeffrey Jacqmein ◽  
...  

The world as we knew it changed at the beginning of 2020 with the explosion of the global pandemic caused by SARS-CoV-2, a.k.a. COVID-19. As of January 10, 2021, the novel coronavirus has infected over 89 million people worldwide and killed over 1.9 million. In the U.S., there have been 22 million people infected and 373,000 deaths. It has never been more important to protect our vulnerable patients and staff from infectious disease, especially during the time they spend in our offices and clinics. It quickly became apparent that there was a need for a dedicated location where patients could be seen that were too ill to be evaluated via telemedicine, but not ill enough to be sent to the Emergency Department (ED). To fill this need, our primary care network developed the Respiratory Evaluation Clinic (REC) concept. These were two geographical locations where the outlying clinics could send potentially infectious patients to evaluate and test COVID-19. Some recommendations, adaptations, lessons learned and the REC clinics' expansions to other locations throughout our network are discussed.


2021 ◽  
Vol 49 (2) ◽  
pp. 66-79
Author(s):  
Shannon Havlicak Grondel

Today is October 1, 2020. In this moment, over 34 million bodies—that we know of—have hosted a deadly virus and more than one million of those bodies have succumbed to the strain of their unwelcome, malignant guest. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)—genetically related to, yet different from the coronavirus responsible for the 2003 SARS outbreak—is the virus that causes coronavirus disease 2019 (COVID-19). The virus first materialized in Wuhan, Hubei province, China as early as November 17, 2019, and quickly escalated from a small cluster of cases of what appeared to be pneumonia to a global pandemic by March 11, 2020.


2021 ◽  
Vol 27 ◽  
Author(s):  
Md. Mominur Rahman ◽  
Muniruddin Ahmed ◽  
Mohammad Touhidul Islam ◽  
Md. Robin Khan ◽  
Sharifa Sultana ◽  
...  

: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a pivotal role during this pandemic. Unluckily, there is no specific drug that can treat patients who are confirmed with COVID-19, though favipiravir and remdesivir have appeared as favorable antiviral drugs. Some vaccines have already developed, and vaccination has started worldwide. Different nanotechnologies are in the developing stage in many countries for preventing SARS-COV-2 and treating COVID-19 conditions. In this article, we review the COVID-19 pandemic situation as well as the nanotechnology-based approaches and investigational therapeutics against COVID-19.


Author(s):  
VALENTINA TJANDRA DEWI ◽  
ANAK AGUNG AYU PUTRI LAKSMIDEWI ◽  
KETUT AYU SUDIARIANI

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or CoV disease 2019 (COVID-19) infection has spread throughout the world and becomes a global pandemic. Various studies are still ongoing to be able to understand this viral infection in terms of symptomatology, transmission, pathogenesis, its treatment, and prevention. In addition to respiratory symptoms that are commonly reported in SARS-CoV-2 infections, there are many reports of symptoms appearing in other organ systems with one of them being neurological manifestation. The neurological manifestations involve not only the central and peripheral nervous systems but also there was also a suspicion that the potential invasion of SARS-CoV-2 in the nervous system might be able to take part in the occurrence of respiratory failure that is found in patients with COVID-19. The continuity of the study and the awareness of medical personnel from various fields of science must be increased to fight against the COVID-19 pandemic and ensuring optimal treatment for patients.


Asian Survey ◽  
2009 ◽  
Vol 49 (1) ◽  
pp. 88-97 ◽  
Author(s):  
Thomas B. Gold

The opposition Kuomintang (KMT) won overwhelming victories in the Legislative Yuan and presidential elections, leaving the Democratic Progressive Party (DPP) demoralized and in disarray. Former President Chen Shui-bian was indicted on corruption charges and jailed pending trial. New President Ma Yingjeou moved quickly to improve relations across the Taiwan Strait, and the long-delayed Three Links (direct air, shipping, and postal service) began in December. Taiwan's economy fared badly along with much of the rest of the world.


Author(s):  
Diego Centonze ◽  
Maria A. Rocca ◽  
Claudio Gasperini ◽  
Ludwig Kappos ◽  
Hans-Peter Hartung ◽  
...  

AbstractCoronavirus disease (COVID-19) appeared in December 2019 in the Chinese city of Wuhan and has quickly become a global pandemic. The disease is caused by the severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2), an RNA beta coronavirus phylogenetically similar to SARS coronavirus. To date, more than 132 million cases of COVID19 have been recorded in the world, of which over 2.8 million were fatal (https://coronavirus.jhu.edu/map.html). A huge vaccination campaign has started around the world since the end of 2020. The availability of vaccines has raised some concerns among neurologists regarding the safety and efficacy of vaccination in patients with multiple sclerosis (MS) taking immunomodulatory or immunosuppressive therapies.


F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 570 ◽  
Author(s):  
Hector Florez ◽  
Sweta Singh

The 2019-2020 global pandemic has been caused by a disease called coronavirus disease 2019 (COVID-19). This disease has been caused by the Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2). By April 30 2020, the World Health Organization reported 3,096,626 cases and 217,896 deaths, which implies an exponential growth for infection and deaths worldwide. Currently, there are various computer-based approaches that present COVID-19 data through different types of charts, which is very useful to recognise its behavior and trends. Nevertheless, such approaches do not allow for observation of any projection regarding confirmed cases and deaths, which would be useful to understand the trends of COVID-19. In this work, we have designed and developed an online dashboard that presents actual information about COVID-19. Furthermore, based on this information, we have designed a mathematical model in order to make projections about the evolution of cases and deaths worldwide and by country.


Sign in / Sign up

Export Citation Format

Share Document